Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?

BACKGROUND: Circulating Neprilysin (sNEP) has emerged as a potential prognostic biomarker in heart failure (HF). In PARAGON-HF benefit of sacubitril/valsartan was only observed in patients with left ventricular ejection fraction (LVEF) ≤57%. We aimed to assess the prognostic value of sNEP in outpati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupón, Josep, Santiago-Vacas, Evelyn, Cediel, Germán, Codina, Pau, Domingo, Mar, Revuelta-López, Elena, Zamora, Elisabet, Spitaleri, Giosafat, Santesmases, Javier, Núñez, Julio, Bayes-Genis, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121351/
https://www.ncbi.nlm.nih.gov/pubmed/33989294
http://dx.doi.org/10.1371/journal.pone.0249674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121351/
https://www.ncbi.nlm.nih.gov/pubmed/33989294
http://dx.doi.org/10.1371/journal.pone.0249674

Ejemplares similares